| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.1 |